Issue of Equity

Provexis PLC
06 June 2006



6 June 2006

                                   PROVEXIS PLC

                           ('Provexis' or the 'Company')

               Standby Equity Distribution Agreement for up to £3m

Provexis, the nutraceutical company that develops scientifically-proven
functional and medical foods, announces that on 5 June 2006, it entered into a
Standby Equity Distribution Agreement ('SEDA') with Cornell Capital Partners, LP
('Cornell').

Pursuant to the SEDA, the Company may, at its discretion, periodically sell to
Cornell, ordinary shares of 1p each in the Company, for a total purchase price
of up to £3.0 million. For each ordinary share purchased under the SEDA, Cornell
will pay the Company 95 per cent. of the lowest volume weighted average price of
the Company's ordinary shares for the 5 days immediately following the notice
date. Cornell will also retain 5 per cent. of each advance under the SEDA.
Cornell's obligation to purchase the ordinary shares under the SEDA is limited
to £50,000 per weekly advance. The amount and timing of all advances under the
SEDA are at the discretion of the Company and the Company is not obligated to
issue and sell any securities to Cornell, unless and until it decides to do so.

In connection with the SEDA arrangement, an implementation fee of £90,000 will
be paid to Cornell by the issue of 1,037,608 new ordinary shares of 1p each.
Application has been made for the admission of the 1,037,608 new ordinary shares
to trading on AIM, and dealings are expected to commence on 12 June 2006.

Dr Stephen Franklin, the CEO of Provexis, said,

'We are very pleased to have entered into this agreement with Cornell Capital.
The SEDA is an innovative product which provides the Company with financial
assurance for the short to medium-term. Should we choose to use it, the facility
provides us with advances at our discretion thereby increasing our options and
strengthening our position.'

For further information please contact:

Stephen Franklin, Chief Executive
Provexis plc                                           Tel: [phone]

Victoria Geoghegan
Bell Pottinger Corporate & Financial                   Tel: [phone]

Tom Griffiths                                          Tel: [phone]
Arbuthnot Securities Limited



                      This information is provided by RNS
            The company news service from the London Stock Exchange